即将进入2026年——十五五的开局之年，多家主流券商在其2026年度策略报告中指出：“创新”已成为贯穿全行业的核心主线，并在此基础上衍生出“出海”“消费复苏”“多元支付”和“硬科技突破”四大战略方向，聚焦创新药、CXO、医疗器械、中药、医疗服务五大板块。#01创新药国际地位提升，出海成为主旋律创新药国际地位显著提升。中国药企在全球创新药市场地位不断提升，中国药企临床占比已与美国相当。近年来，中国...
Source Link即将进入2026年——十五五的开局之年，多家主流券商在其2026年度策略报告中指出：“创新”已成为贯穿全行业的核心主线，并在此基础上衍生出“出海”“消费复苏”“多元支付”和“硬科技突破”四大战略方向，聚焦创新药、CXO、医疗器械、中药、医疗服务五大板块。#01创新药国际地位提升，出海成为主旋律创新药国际地位显著提升。中国药企在全球创新药市场地位不断提升，中国药企临床占比已与美国相当。近年来，中国...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.